Affordable Medicines Europe represents Europe’s licensed parallel distribution industry, an integral part of the European pharmaceutical market that adds value to society by introducing price competition – especially for patented medicines – and a supplementary layer of product safety. In this our members work everyday to make medicines more affordable for European healthcare systems and patients.
Our industry has an annual turnover of 5.5 billion Euro. We have more than 120 companies in 23 EU/EEA Member States as members. These members account for approximately 80% of the total parallel import market volume in the EU/EEA. Membership of Affordable Medicines Europe is exclusive to companies holding a wholesale (GDP) license (export and import). All importing members furthermore are GMP licensed.
Affordable Medicines Europe is managed from Brussels by our Secretariat.